Skip to main content
. 2021 Jun 1;7:11. doi: 10.1038/s41514-021-00064-9

Table 3.

iMAT-based metabolic network modeling of cholesterol synthesis and catabolism in AD.

ERC Hippocampus Visual cortex
Gene Human GEM rxn ID GEM reaction Odds ratio P value Odds ratio P value Odds ratio P value
De novo cholesterol biosynthesis (pre-squalene mevalonate pathway)
ACAT2 HMR_1434 acetoacetyl-CoA[c] + CoA[c] <=> 2 acetyl-CoA[c] 1.500 1.000 0.070 0.006 0.000 0.510
HMGCS1 HMR_1437 acetoacetyl-CoA[c] + acetyl-CoA[c] + H2O[c] => CoA[c] + H+[c] + HMG-CoA[c] 0.721 0.603 0.178 0.028 1.018 1.000
HMGCR HMR_1440 2 H+[c] + HMG-CoA[c] + 2 NADPH[c] => (R)-mevalonate[c] + CoA[c] + 2 NADP+[c] 0.522 0.322 0.087 0.016 0.000 0.265
De novo cholesterol biosynthesis (post-squalene mevalonate pathway including Bloch and Kandutch-Russell)
SC5D 7DHCHSTEROLtr 7-dehydrocholesterol[r] <=> 7-dehydrocholesterol[c] 0.353 0.049 0.518 0.204 1.786 0.676
DHCR7 HMR_1565 H+[c] + NADPH[c] + 7-dehydrocholesterol[c] => cholesterol[c] + NADP+[c] 0.248 0.009 0.308 0.097 3.929 0.363
DHCR7 DHCR72r H+[r] + NADPH[r] + 7-dehydrocholesterol[r] => cholesterol[r] + NADP+[r] 0.308 0.023 0.171 0.008 1.786 0.676
SC4MOL, SC5D C14STRr H+[r] + NADPH[r] + 4,4-dimethyl-5alpha-cholesta-8,14,24-trien-3-beta-ol[r] => NADP+[r] + 14-demethyllanosterol[r] 0.144 0.001 0.121 0.000 0.134 0.021
SC4MOL C4STMO2Pr NADP+[r] + O2[r] + 3-keto-4-methylzymosterol[r] => CO2[r] + H+[r] + NADPH[r] + zymosterol Intermediate 2[r] 0.750 1.000 0.000 0.047 NA 1.000
SC5D HMR_1516 5alpha-cholesta-7,24-dien-3-beta-ol[c] + H+[c] + NADPH[c] + O2[c] => 7-dehydrodesmosterol[c] + 2 H2O[c] + NADP+[c] 0.188 0.002 0.186 0.006 Inf 0.265
SC5D LSTO1r H+ [r] + NADPH[r] + O2[r] + 5alpha-cholesta-7,24-dien-3-beta-ol[r] => 2 H2O[r] + NADP+[r] + 7-dehydrodesmosterol[r] 0.000 0.031 NA 1.000 0.000 0.510
DHCR7 HMR_1519 7-dehydrodesmosterol[c] + H+[c] + NADPH[c] => desmosterol[c] + NADP+[c] 0.188 0.002 0.186 0.006 Inf 0.265
DHCR7 DHCR71r H+[r] + NADPH[r] + 7-dehydrodesmosterol[r] => NADP+ [r] + desmosterol[r] 0.000 0.031 NA 1.000 0.000 0.510
DHCR24 HMR_1526 desmosterol[c] + H+[c] + NADPH[c] => cholesterol[c] + NADP+[c] 0.103 0.036 0.000 0.341 0.000 0.510
DHCR24 DSREDUCr H+[r] + NADPH[r] + desmosterol[r] => cholesterol[r] + NADP+[r] 0.103 0.036 0.000 0.341 0.000 0.510
DHCR24 DSMSTEROLtr desmosterol[r] => desmosterol[c] 1.083 1.000 2.824 0.035 0.000 0.139
Cholesterol catabolism (enzymatic)
HSD3B7 HMR_1738 cholest-5-ene-3-beta,7alpha,24(S)-triol[c] + NAD+[c] => 4-cholesten-7alpha,24(S)-diol-3-one[c] + H+[c] + NADH[c] 4.164 0.021 2.724 0.116 2.400 0.288

GEM genome-scale metabolic model, Human-GEM rxn ID Human GEM reaction ID is searchable in metabolicatlas.org and indicates the specific reaction equation and additional reaction details, AD Alzheimer’s disease, CN control, ERC entorhinal cortex, [c] cytoplasm, [m] mitochondria, [r] endoplasmic reticulum; P < 0.05 in bold.

Significant (P < 0.05) odds ratios <1.0 indicate that the reaction is less active in AD compared to CN; significant odds ratios >1.0 indicate that the reaction is more active in AD compared to CN. Note that all significant de novo cholesterol biosynthesis reactions other than DSMSTEROLtr are less active in AD compared to CN. “Inf” indicates that one of the values for calculating the odds ratio (either the number of AD or CN samples that were either active or inactive for a particular reaction) was 0. “NA” indicates two of the values for calculating the odds ratio (the number of AD and CN samples that were either active or inactive for a particular reaction) was 0. Significant associations (P < 0.05) are indicated in bold. Gene Expression Ominbus (GEO) data sample size: ERC: AD (n = 25), CN (n = 52); hippocampus: AD (n = 29), CN (n = 56); visual cortex: AD (n = 18), CN (n = 12).